Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
ACS Chemical Neuroscience
|
May 2, 2013
Age-related changes in melatonin release in the murine distal colon
Lucy B Diss, Stephen D Robinson, Yukyee Wu, et al.
Communications Biology
|
May 24, 2024
A proteomics approach to isolating neuropilin-dependent α5 integrin trafficking pathways: neuropilin 1 and 2 co-traffic α5 integrin through endosomal p120RasGAP to promote polarised fibronectin fibrillogenesis in endothelial cells
Christopher J Benwell, Robert T Johnson, James A G E Taylor, et al.
International Journal of Cancer
|
February 1, 2021
Exploring the impact of gut microbiota and diet on breast cancer risk and progression
Nancy M Y Teng, Christopher A Price, Alastair M McKee, et al.
Cancer Research Communications
|
March 27, 2023
Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis
Christopher J Benwell, Robert T Johnson, James A G E Taylor, et al.
Scientific Reports
|
October 6, 2017
Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling
Peng Liu, Samuel J Atkinson, Sophia E Akbareian, et al.
Journal of Cell Science
|
April 10, 2020
ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis
Jordi Lambert, Kate Makin, Sophia Akbareian, et al.
Frontiers in Cell and Developmental Biology
|
June 13, 2020
NRP2 as an Emerging Angiogenic Player; Promoting Endothelial Cell Adhesion and Migration by Regulating Recycling of α5 Integrin
Abdullah A A Alghamdi, Christopher J Benwell, Samuel J Atkinson, et al.
Plos One
|
May 16, 2013
Stromal Claudin14-heterozygosity, but not deletion, increases tumour blood leakage without affecting tumour growth
Marianne Baker, Louise E Reynolds, Stephen D Robinson, et al.
Oncotarget
|
December 20, 2018
Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
Kimberley Hanson, Stephen D Robinson, Karamallah Al-Yousuf, et al.
Oncotarget
|
February 10, 2018
The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
Kimberley Hanson, Stephen D Robinson, Karamallah Al-Yousuf, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
ACS Chemical Neuroscience
|
May 2, 2013
Age-related changes in melatonin release in the murine distal colon
Lucy B Diss, Stephen D Robinson, Yukyee Wu, et al.
Communications Biology
|
May 24, 2024
A proteomics approach to isolating neuropilin-dependent α5 integrin trafficking pathways: neuropilin 1 and 2 co-traffic α5 integrin through endosomal p120RasGAP to promote polarised fibronectin fibrillogenesis in endothelial cells
Christopher J Benwell, Robert T Johnson, James A G E Taylor, et al.
International Journal of Cancer
|
February 1, 2021
Exploring the impact of gut microbiota and diet on breast cancer risk and progression
Nancy M Y Teng, Christopher A Price, Alastair M McKee, et al.
Cancer Research Communications
|
March 27, 2023
Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis
Christopher J Benwell, Robert T Johnson, James A G E Taylor, et al.
Scientific Reports
|
October 6, 2017
Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling
Peng Liu, Samuel J Atkinson, Sophia E Akbareian, et al.
Journal of Cell Science
|
April 10, 2020
ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis
Jordi Lambert, Kate Makin, Sophia Akbareian, et al.
Frontiers in Cell and Developmental Biology
|
June 13, 2020
NRP2 as an Emerging Angiogenic Player; Promoting Endothelial Cell Adhesion and Migration by Regulating Recycling of α5 Integrin
Abdullah A A Alghamdi, Christopher J Benwell, Samuel J Atkinson, et al.
Plos One
|
May 16, 2013
Stromal Claudin14-heterozygosity, but not deletion, increases tumour blood leakage without affecting tumour growth
Marianne Baker, Louise E Reynolds, Stephen D Robinson, et al.
Oncotarget
|
December 20, 2018
Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
Kimberley Hanson, Stephen D Robinson, Karamallah Al-Yousuf, et al.
Oncotarget
|
February 10, 2018
The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
Kimberley Hanson, Stephen D Robinson, Karamallah Al-Yousuf, et al.
Page
of 6